Investment Research & Advisory Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,805
Closed -$1.09M 225
2023
Q4
$1.09M Sell
4,805
-479
-9% -$101K 0.56% 39
2023
Q3
$1.06M Sell
5,284
-1,724
-25% -$364K 0.6% 41
2023
Q2
$1.45M Buy
7,008
+135
+2% +$26.2K 0.84% 36
2023
Q1
$1.35M Buy
6,873
+1,111
+19% +$229K 0.87% 35
2022
Q4
$1.17M Sell
5,762
-850
-13% -$166K 0.77% 33
2022
Q3
$1.16M Buy
6,612
+138
+2% +$28.3K 0.87% 34
2022
Q2
$1.3M Sell
6,474
-913
-12% -$195K 0.94% 34
2022
Q1
$1.67M Buy
7,387
+7,039
+2,023% +$1.66M 1.05% 29
2021
Q4
$94K Buy
348
+150
+76% +$37.1K 0.06% 85
2021
Q3
$48K Hold
198
0.03% 100
2021
Q2
$47K Hold
198
0.03% 110
2021
Q1
$43K Hold
198
0.03% 103
2020
Q4
$35K Buy
+198
New +$34.2K 0.03% 107
2020
Q1
Sell
-222
Closed -$32K 167
2019
Q4
$32K Buy
+222
New +$32.1K 0.03% 120

Other funds holding LH

Investment Research & Advisory Group's LH Position: Q1 2024 in Review

Investment Research & Advisory Group sold out of Labcorp (LH) in Q1 2024, closing a stake of 4,805 shares — an estimated $1.09M sold.

Investment Research & Advisory Group first reported a position in LH in Q4 2019 and held it in 14 quarters. The position peaked at $1.67M in Q1 2022. 928 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Investment Research & Advisory Group reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Investment Research & Advisory Group sold 4,805 Labcorp shares in Q1 2024, an estimated $1.09M.
  • Investment Research & Advisory Group first reported a position in Labcorp in Q4 2019 and held it in 14 quarters.
  • Investment Research & Advisory Group's Labcorp position peaked at $1.67M in Q1 2022.
  • 928 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Investment Research & Advisory Group's 13F filing for Q1 2024, filed 17 Apr 2024.